New combination acne treatment

Epiduo (adapalene 0.1% + benzoyl peroxide 2.5%) is a new anti-acne gel containing two agents with complementary mechanisms of action.

Adapalene (Differin) is thought to modulate cellular differentiation and keratinisation; it also has anti-inflammatory activity. Benzoyl peroxide has ketatolytic, exfoliative, sebostatic and antimicrobial properties.

Two 12-week, randomised, double-blind studies of Epiduo were conducted in a total of 2185 patients. The gel produced greater reductions in lesion counts and had higher success rates (proportion of patients rated ‘clear' or ‘almost clear') than either of the active components alone, or placebo (gel vehicle).

View Epiduo drug record

Further information: Galderma

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases